Rhythm Pharmaceuticals, Inc.: Leerink Partners raises target price to $137 from $133
RYTM•Leerink Partners raised its target price on Rhythm Pharmaceuticals to $137 from $133.
Related News
Booz Allen Hamilton announces availability of fiscal 2027 second-quarter earnings release
BAH•
Wall Street futures dip after AI rout, telecoms slide
SPY•
HubSpot target price raised to $300 from $250
HUBS•
TSX futures slip as oil rally adds to inflation worries
SPY•
Flagstar Bank slips as rate pressure hits 2027 forecast
FLG•